Polyarteritis nodosa natural history, complications and prognosis

Jump to navigation Jump to search

Polyarteritis nodosa Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Polyarteritis nodosa from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiography

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Polyarteritis nodosa natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Polyarteritis nodosa natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Polyarteritis nodosa natural history, complications and prognosis

CDC on Polyarteritis nodosa natural history, complications and prognosis

Polyarteritis nodosa natural history, complications and prognosis in the news

Blogs on Polyarteritis nodosa natural history, complications and prognosis

Directions to Hospitals Treating Polyarteritis nodosa

Risk calculators and risk factors for Polyarteritis nodosa natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Haritha Machavarapu, M.B.B.S.Sargun Singh Walia M.B.B.S.[3]

Overview

PAN if left untreated, the disease is fatal in most cases. The most serious associated conditions generally involve the kidneys and gastrointestinal tract. Common complications of PAN include Stroke,Kidney failure, heart attack,Intestinal necrosis and perforation. Prognosis is generally good if the treatment is started.Therapy results in remissions or cures in 90% of cases. Guillevin and coworkers have described five prognostic factors that predict high probability of mortality and are considered indications for another immunosuppressive drug in addition to prednisone.

Natural History

  • PAN if left untreated, the disease is fatal in most cases.
  • The most serious associated conditions generally involve the kidneys and gastrointestinal tract.
  • Without treatment, the outlook is poor.

Complications

Prognosis

  • Prognosis is generally good if the treatment is started.
  • Therapy results in remissions or cures in 90% of cases.
  • Current treatments using steroids and other drugs that suppress the immune system (such as cyclophosphamide) can improve symptoms and the chance of long-term survival.[1]
  • Guillevin and coworkers have described five prognostic factors that predict high probability of mortality and are considered indications for another immunosuppressive drug in addition to prednisone.[2]
  1. Proteinuria >1g/day
  2. Azotemia
  3. Cardiomyopathy
  4. Gastrointestinal involvement
  5. Central nervous system disease With none of these factors, 5-year mortality is 12%. With 2 or more 5-year mortality is 46%[3]

References

  1. Leib ES, Restivo C, Paulus HE (December 1979). "Immunosuppressive and corticosteroid therapy of polyarteritis nodosa". Am. J. Med. 67 (6): 941–7. PMID 42314.
  2. Guillevin L, Lhote F, Gayraud M, Cohen P, Jarrousse B, Lortholary O, Thibult N, Casassus P (January 1996). "Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients". Medicine (Baltimore). 75 (1): 17–28. PMID 8569467.
  3. Kelley's Textbook of Rheumatology,8th edition

Template:WH Template:WS